[go: up one dir, main page]

AU3972178A - Prostaglandin composition and method - Google Patents

Prostaglandin composition and method

Info

Publication number
AU3972178A
AU3972178A AU39721/78A AU3972178A AU3972178A AU 3972178 A AU3972178 A AU 3972178A AU 39721/78 A AU39721/78 A AU 39721/78A AU 3972178 A AU3972178 A AU 3972178A AU 3972178 A AU3972178 A AU 3972178A
Authority
AU
Australia
Prior art keywords
prostaglandin composition
prostaglandin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU39721/78A
Inventor
Gunther Dietze
Matthias Wicklmayr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Original Assignee
Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte filed Critical Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Publication of AU3972178A publication Critical patent/AU3972178A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU39721/78A 1977-09-12 1978-09-11 Prostaglandin composition and method Pending AU3972178A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772740953 DE2740953A1 (en) 1977-09-12 1977-09-12 USE OF PROSTAGLANDINES TO LOWER BLOOD SUGAR LEVELS

Publications (1)

Publication Number Publication Date
AU3972178A true AU3972178A (en) 1980-03-20

Family

ID=6018706

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39721/78A Pending AU3972178A (en) 1977-09-12 1978-09-11 Prostaglandin composition and method

Country Status (4)

Country Link
EP (1) EP0001124A1 (en)
JP (1) JPS5449331A (en)
AU (1) AU3972178A (en)
DE (1) DE2740953A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648877B2 (en) * 1991-03-14 1994-05-05 Sucampo Ag Promotion of wound-healing with 15-keto prostaglandin compounds
WO2024107118A1 (en) * 2022-11-16 2024-05-23 Nanyang Technological University Nor1 ligands and methods of their use

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
US4937265A (en) * 1987-05-28 1990-06-26 Teijin Limited Antidiabetic method comprising 7-thiaprostaglandin E1 or its derivatives
JO3624B1 (en) 2014-05-08 2020-08-27 Lilly Co Eli Fast acting insulin formulations
WO2017015760A1 (en) 2015-07-28 2017-02-02 Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines, S.E.C. A pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin
JO3749B1 (en) 2015-08-27 2021-01-31 Lilly Co Eli Rapid-acting insulin compositions
EA202190552A1 (en) 2018-09-18 2021-06-18 Эли Лилли Энд Компани TREPROSTINIL ERBUMIN SALT

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU419560B2 (en) * 1969-01-09 1971-12-03 Mary Philomena Earle Sister Improvements inthe administration of insulin
FR2157899A1 (en) * 1971-10-22 1973-06-08 Upjohn Co 16-mono and di-lower alkyl prostaglandin compsns - - for treatment of peptic ulcers
BE790840A (en) * 1971-11-01 1973-04-30 Upjohn Co UNSTABLE DRUG SOLUTIONS AND THEIR PREPARATION
US3882245A (en) * 1972-11-01 1975-05-06 Upjohn Co Use of prostaglandins in combating shock
US3851052A (en) * 1972-11-08 1974-11-26 Pfizer Stabilized e-series prostaglandins
DE2317139A1 (en) * 1973-04-05 1974-10-17 Thomae Gmbh Dr K Potentiated antidiabetic medicaments - contg. a sulphonylurea or sulphon-amide antidiabetic agent together with dihydroergotamine
US4009282A (en) * 1973-12-17 1977-02-22 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with prostaglandins
AU7003774A (en) * 1974-06-13 1975-12-18 Otsuka Pharma Co Ltd Parenteral feeding method
DE2433173C3 (en) * 1974-07-10 1980-02-07 J. Pfrimmer & Co, 8520 Erlangen Use of cholanic acid derivatives
US3966962A (en) * 1975-03-27 1976-06-29 The Upjohn Company Triacetin solutions of PGE-type compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648877B2 (en) * 1991-03-14 1994-05-05 Sucampo Ag Promotion of wound-healing with 15-keto prostaglandin compounds
WO2024107118A1 (en) * 2022-11-16 2024-05-23 Nanyang Technological University Nor1 ligands and methods of their use

Also Published As

Publication number Publication date
JPS5449331A (en) 1979-04-18
EP0001124A1 (en) 1979-03-21
DE2740953A1 (en) 1979-03-22

Similar Documents

Publication Publication Date Title
JPS5416453A (en) Composition and method
JPS5464695A (en) Substance composition and method
JPS5422208A (en) Method of photogravuring
GB2000030A (en) Bacteriostatic composition and method
JPS549265A (en) Composition and method
JPS5481304A (en) Severe method of property improvement
JPS5492953A (en) Composition and method
JPS53127383A (en) Scale controlling composition and controlling method
AU3972178A (en) Prostaglandin composition and method
JPS5490124A (en) Method of reduction
ZA784539B (en) Prostaglandin method
ZA783241B (en) Method
JPS549152A (en) Method of making stairinggheaddpipe
JPS53120754A (en) Fillerrcontaining composition and method of making same
JPS549153A (en) Method of making stairinggheaddpipe
JPS5492952A (en) Composition and method
JPS53119833A (en) Method of purieying ppphenylenediamine
JPS542400A (en) Vinegar making method
JPS5399316A (en) Stbilyzing method of leserpine preparation
JPS5419961A (en) Composition and method
JPS53112894A (en) Method of etherizing
JPS53141027A (en) Method of preventing
JPS53100620A (en) Method of connecting hhbeam
JPS5427557A (en) Composition and method
JPS53148807A (en) Method of construction